Position in APRE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$12,873
-$3,189 QoQ
Shares Held
16,052
-23.8% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 28 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in APRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $557,763,742 across 203 Biotechnology names. APRE ranks #196 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,111 | $143,610,107 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,755 | $41,000,872 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
310,761 | $25,330,129 | |
| 4 | ARGX |
Argenx SE
|
19,499 | $18,090,587 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,890 | $17,426,626 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
203,557 | $15,932,406 | |
| 7 | RPRX |
Royalty Pharma plc
|
249,117 | $13,967,990 | |
| 8 | INSM |
INSMED Inc
|
128,553 | $13,706,320 |
All Filings in APRE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,873 | 16,052 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $16,062 | 21,052 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $22,222 | 26,052 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $23,676 | 16,052 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $28,817 | 17,052 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $32,746 | 16,052 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $52,811 | 16,052 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||